CRXT

15-12G - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

8-K - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

S-8 POS - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

POS AM - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

POS AM - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

POS AM - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

POS AM - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

8-K - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

SC 13G/A - Clarus Therapeutics Holdings, Inc. (0001817944) (Subject)

8-K - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

8-K - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

8-K - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

8-K - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

8-K - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

8-K - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

Court-supervised auction for JATENZO (testosterone undecanoate capsules; C-III) concluded on October 14, 2022 NORTHBROOK, Ill., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (OTC:CRXTQ), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen therapies, announced today that, subject to entry into definitive documentation, it and its wholly-owned subsidiary, Clarus Therapeutics, Inc., selected Tolmar, Inc., (Buffalo Grove, IL) as the winning bidder in a competitive bidding and auction proceeding for the sale of JATENZO (and certain related assets). The bidding and auction procedures were approved by the U. S. Ba

8-K - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

25-NSE - Clarus Therapeutics Holdings, Inc. (0001817944) (Subject)

8-K - Clarus Therapeutics Holdings, Inc. (0001817944) (Filer)

NORTHBROOK, Ill., Sept. 05, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (OTC:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen therapies, announced today that it, together with its wholly-owned subsidiary Clarus Therapeutics, Inc., has filed voluntary petitions under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware (the Court). Clarus has also filed a motion seeking authorization to pursue an auction and sale process under Section 363 of the U.S. Bankruptcy Code of its sole commercial asset, JATENZO, that is approved for use by healthcare providers to treat testos

Gainers Mobile Global Esports Inc. (NASDAQ:MGAM) shares surged 103.9% to settle at $5.30 on Tuesday. Shares are in low-float territory; the issue has about 15 million shares in its float. NewAge, Inc. (NASDAQ:NBEV) shares jumped 74.2% to close at $0.3632 on Tuesday. IN8bio, Inc. (NASDAQ:INAB) surged 39.4% to settle at $2.76 after a Form 4 Filing showed Cavu Advisors purchased 51,214 shares at an average price of $2.02. HC Wainwright & Co. initiated coverage on IN8bio with a Buy rating and announced a price target of $14. TMC the metals company Inc. (NASDAQ:TMC) jumped 33.3% to close at $1.12. The company recently posted a quarterly loss of $0.05 per share. TDH Holdings, Inc. (NASDAQ:P

Gainers NewAge, Inc. (NASDAQ:NBEV) rose 54.4% to $0.3220. IN8bio, Inc. (NASDAQ:INAB) jumped 46% to $2.89 after a Form 4 Filing showed Cavu Advisors purchased 51,214 shares at an average price of $2.02. HC Wainwright & Co. initiated coverage on IN8bio with a Buy rating and announced a price target of $14. Mobile Global Esports Inc. (NASDAQ:MGAM) shares jumped 45% to $3.7705. Shares are in low-float territory; the issue has about 15 million shares in its float. Forge Global Holdings, Inc. (NYSE:FRGE) gained 26.7% to $4.37. Virax Biolabs Group Limited (NASDAQ:VRAX) gained 20% to $3.94. American Outdoor Brands, Inc. (NASDAQ:AOUT) surged 18% to $9.17 after B. Riley upgraded the stock from

  On Tuesday, 250 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows: Toyota Motor (NYSE:TM) was the biggest company on a market cap basis to set a new 52-week low. SciSparc (NASDAQ:SPRC) was the smallest firm by market cap to set a new 52-week low. Rubicon Technology (NASDAQ:RBCN)'s stock traded down the lowest, falling 74.66% to reach a new 52-week low. Grupo Aval Acciones (NYSE:AVAL)'s stock made the biggest reversal, trading up 0.0% shortly after dropping to a new 52-week low. On Tuesday, the following stocks set new 52-week lows: Toyota Motor (NYSE:TM) stock drifted down 0.45% on Tuesday morning to hit a new 52-week low of $150.59. Comcast (NASDA

Gainers Mobile Global Esports Inc. (NASDAQ:MGAM) shares rose 28.1% to $3.33 in pre-market trading after gaining over 5% on Monday. The company recently reported an exclusive compression technology partnership for upcoming Indian esports social-gaming platform. American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) shares rose 18.3% to $0.4435 in pre-market trading after jumping 156% on Monday. American Virtual Cloud Technologies recently announced changes to its board of directors and management team, along with the launch of a review to explore the sale of the entire business or selected assets. Sharps Technology, Inc. (NASDAQ:STSS) rose 13.7% to $1.58 in pre-market trading. NewAge,

Clarus Therapeutics Holdings Inc (NASDAQ:CRXT) shares traded lower by 32.24% to $0.14 during Monday's trading session after the company announced it has received a non-compliance letter from Nasdaq. The shares will be suspended on August 31st and will begin trading on the OTC Pink Market. What Else? Clarus Therapeutics says, as previously disclosed on February 18th, 2022, the company received two written notifications from the Listing Qualifications Department of Nasdaq. Clarus Therapeutics says the first notification indicated that as of February 18th, Clarus did not meet the $15,000,000 minimum market value of publicly held shares required to maintain continued listing as set forth in N